HSPA1B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.580500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.442300E-02
Normal-vs-Stage2
5.837800E-04
Normal-vs-Stage3
2.061000E-01
Normal-vs-Stage4
1.377440E-01
Stage1-vs-Stage2
1.893570E-02
Stage1-vs-Stage3
4.146200E-01
Stage1-vs-Stage4
2.386200E-01
Stage2-vs-Stage3
9.365000E-01
Stage2-vs-Stage4
7.480200E-01
Stage3-vs-Stage4
5.441800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.174900E-04
Normal-vs-AfricanAmerican
9.419700E-02
Normal-vs-Asian
3.153400E-01
Caucasian-vs-AfricanAmerican
6.464000E-01
Caucasian-vs-Asian
8.128400E-01
AfricanAmerican-vs-Asian
9.306600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.001090E-03
Normal-vs-Female
4.150400E-01
Male-vs-Female
8.509600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.056200E-02
Normal-vs-Age(41-60Yrs)
2.174500E-02
Normal-vs-Age(61-80Yrs)
1.401500E-03
Normal-vs-Age(81-100Yrs)
7.301900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.444400E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.096200E-03
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.977200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.256400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.464990E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.544100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.448000E-01
Normal-vs-Daily Drinker
3.955800E-02
Normal-vs-Weekly Drinker
7.790300E-02
Normal-vs-Occasional Drinker
7.742500E-03
Normal-vs-Social Drinker
1.099440E-01
Non Drinker-vs-Daily Drinker
7.089200E-01
Non Drinker-vs-Weekly Drinker
3.580000E-01
Non Drinker-vs-Occasional Drinker
2.849400E-01
Non Drinker-vs-Social Drinker
4.168000E-02
Daily Drinker-vs-Weekly Drinker
4.574200E-01
Daily Drinker-vs-Occasional Drinker
5.873000E-01
Daily Drinker-vs-Social Drinker
1.408430E-01
Weekly Drinker-vs-Occasional Drinker
7.429400E-01
Weekly Drinker-vs-Social Drinker
1.447790E-01
Occasional Drinker-vs-Social Drinker
3.039800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.820600E-01
Normal-vs-Grade 2
5.819200E-01
Normal-vs-Grade 3
3.451400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.035520E-02
Grade 1-vs-Grade 3
8.004100E-02
Grade 1-vs-Grade 4
1.820600E-01
Grade 2-vs-Grade 3
9.464000E-02
Grade 2-vs-Grade 4
5.819200E-01
Grade 3-vs-Grade 4
3.451400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.200800E-03
Normal-vs-NonDiabetic
1.743930E-03
Diabetic-vs-NonDiabetic
8.413200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.427900E-02
Normal-vs-NoPancreatitis
1.518560E-03
Pancreatitis-vs-NoPancreatitis
3.417000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.874820E-01
Normal-vs-N1
9.763300E-04
N0-vs-N1
2.348600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.681900E-03
Normal-vs-TP53-NonMutant
4.516400E-01
TP53-Mutant-vs-TP53-NonMutant
6.449700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
